Prescription characteristics of non-steroidal anti-inflammatory drugs among the elderly;Características de la prescripción de analgésicos antiinflamatorios no esteroideos en adultos mayores

Gaceta Medica de Mexico

Volumn 143, Issue 1, 2007, Pages 5-9

  Lagunes Espinosa, Alma Luisa ^a,c   Peralta Pedrero, María Luisa ^a   Rodríguez Moctezuma, Raymundo ^a   López Carmona, Juan Manuel ^a   Ibarra Vicens, Emilia ^a   Cruz Avelare, Agles ^b   Murguía Miranda, Catarina ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c NONE   (Mexico)

Author keywords

Adverse side effects; Elderly; Medical prescription; NSAIDs; Pharmacologic interaction

Indexed keywords

ACETYLSALICYLIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRACT; GERIATRIC CARE; HUMAN; INFLAMMATION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PAIN; PRESCRIPTION; PREVALENCE; PROPHYLAXIS; SOCIAL SECURITY; TREATMENT DURATION; CROSS-SECTIONAL STUDY; PROSPECTIVE STUDY; STATISTICS;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES;

EID: 34347252315     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Organización de las Naciones Unidas. Informe de la Segunda. Asamblea Mundial Sobre Envejecimiento, Madrid España, abril 2002.
2. Instituto Nacional de Estadística Geografía e Informática, Estados Unidos Mexicanos. XII Censo General de Población y vivienda 2000.
3. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002;809-817.
4. Arbas E, Garzon R, Suárez A, y cols. Consumo de medicamentos en mayores de 65 años: problemas potenciales y factores asociados. Aten Primaria 1998;22:165-170.
5. Pirmohamed M, James S, Meakin S, Green Ch, Scott AJ, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19.
6. Rathore SS, Mehta SS, Boyko WL, Schulman KA. Prescription medication use in older Americans: a national report card on prescribing. Fam Med 1998;30:733-739.
7. Tomas MT, Centelles F, Valero C. y cols. Prescripción crónica de fármacos de pacientes geriátricos en un centro de salud urbano. Aten Primaria 1999;23:121-126.
8. Herrador MP, Castillo PA. Estudio del consumo de fármacos en la Residencia del IMSERSO de Melia. Resp Esp Geriatr Gerontol 2002;37:134-140.
9. Tannenbaum H, Davis P, Russell AS, Atrinson MH, Maksymowyo et al. An evidence-base approach to prescribing NSAIDS in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants. Can Med Assoc J 1996;15:77-88.
10. Goodman GA, Goodman L, Gilman A. Las bases farmacológicas de la terapéutica.10ed.McGraw-Hill Book Company 2001.
11. García-Zenón T, López-Guzmán J, Roldán-de-la-O I, Almeida-Alvarado J, kVillalobos A, D'Hyver C. Fármacos inapropiados en el anciano: una propuesta de clasificación. Med Int Mex 2005;21:188-189.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
13. Distribución de los adultos mayores según ingreso en salarios mínimos por sexo y entidad federativa en: Indicadores Demográficos para Adultos 2000-2050. Consejo Nacional de Población, México.
14. Huang S. Rheumatology: 7 Basics of therapy. Can Med Assoc J 2000;163:417-423.
15. Schnitzer TJ. Non-NSAID Pharmacologic treatment options for the management of chronic pain. Am J Med 1998;105:45S-52S.
16. Ruoff G. Management of pain in patients with multiple health problems: a guide for the practicing physician. Am J Med 1998;105:53S-60S.
17. Pérez Gutthanns, García-Rodríguez LA, Raiford DS, Duque-Oliazt A, Ris-Romeu J. Nonsteroidal anti-inflammatory drugs and de risk of hospitalization for acute renal failure. Arch Intern Med 1996;156:2433-2439.
18. Griffin MR, Yared A, Wayne R. Nonsteroidal Ant- inflammatory Drugs and acute Renal Failure in Elderly Persons. Am J Epidemiol 2000;15:488-496.
19. Field T, Gurwitz J, Glynn R, Salive ME, Gaziano JM, Taylor JO, Hennekens CH. The Renal Effects of Nonsteroidal Anti-inflammatory Drugs in Older People: Findings from the Established Populations for Epidemiologics Studies of the Elderly. J Am Geriatric Soc 1999;475:507-511.
20. Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H. Initiation of Antihypertensive Treatment During Nonsteroidal Anti-inflammatory Drug Therapy. JAMA 1994:272:781-786.
21. PageJ, Henry D. Consumption of NSADs and the Development of Congestive heart Failure in Elderly Patients: An Under recognized Public health Problem. Arch Intern Med 2000:16:777-784.
22. Rolka DB, Fagot-Campagna A, Venkat KM. Aspirin Use among Adults with Diabetes. Diabetes Care 2001;24:197-201.
23. Krein SL, Vijan S, Pogach LM, Hogan MM, Keer EA. Aspirin Use and Counseling, About Aspirin among Patients with Diabetes. Diabetes Care 2001;25:965-970.
24. Blasco V M, Lucia C J. Revisión de los antiagregantes plaquetarios y sus indicaciones en atención primaria. Ocho años después... Aten Primaria 2003;31:252-263.
25. López de la Iglesia J, Escudero S, González GA, et al. Empleo de antiagregantes en la prevención primaria y secundaria cardiovascular del diabético en el medio urbano y rural del área de León. Aten Primaria 2003;31:361-365.
26. Pérez S, García RLA, Raiford DS, Duque OA, Ris RJ. Nonsteroidal Antiinflamtory Drugs and the Risk of Hospitalization for Acute Renal Failure. Arch Intern Med 1996;56:2433-2439.
27. Hollander D. Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: Prophylactic and therapeutic strategies. Am J Med 1994;96:274-281.
28. Dios del Valle R, Hernández SA, Franco-Vidal A González-Rubio y, Romera Fernández I. Prescripción de antinflamatorios no esteroideos y protectores gástricos en urgencias. Aten Primaria 2003;31:500-505.
29. Griffin M. Epidemiology of nonsteroidal antiinflammatory drug-associated gastrointestinal injury. Am J Med 1998;104:23S-29S.
30. Hollenz M, Stolte M, Leodolter A, Labenz J. NSAID associated dyspepsia and ulcers: a prospective cohort study in primary care. Dig Dis 2006;24:189-194.
31. Oparil S, Zaman MA, Calhoun D. Pathogenesis of Hypertension. Ann Intern Med 2003;139:761-776.
32. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560-2572.